|
|
|
| Mortality and disease burden of diabetes in Hangzhou City from 2013 to 2021 |
| ZHANG Tiewei, ZHANG Yan, LIU Bing, QIN Kang, LI Biao, XU Jue
|
| Department of Non-communicable Diseases Control and Prevention, Hangzhou Center for Disease Control and Prevention, Hangzhou, Zhejiang 310021, China |
|
|
|
|
Abstract Objective To investigate the mortality and disease burden of diabetes in Hangzhou City from 2013 to 2021, so as to provide insights into improving diabetes prevention and control strategies. Methods Data on morbidity and mortality of diabetes in Hangzhou City from 2013 to 2021 were collected through the Chronic Disease and Death Cause Monitoring System of Hangzhou Center for Disease Control and Prevention, and the crude and age-standardized mortality (standardized by the population of the Seventh National Population Census in China in 2020) were calculated. Data on the prevalence of diabetes were collected from the China Chronic Disease and Risk Factors Surveillance (CCDRFS), and the burden of disease was evaluated by calculating years of life lost (YLL), years lived with disability (YLD) and disability-adjusted years (DALY) with reference to the methodology of the Global Burden of Disease Study (GBD). The trends in mortality and disease burden of diabetes were evaluated with the average annual percent change (AAPC). Results There were 8 686 deaths of diabetes in Hangzhou City from 2013 to 2021, with the average annual crude mortality of 13.17/105 and age-standardized mortality of 10.89/105. The crude mortality of diabetes showed a tendency towards a rise (AAPC=2.62%, P<0.05), while the trend in age-standardized mortality was not significant (P>0.05). The crude and age-standardized mortality of diabetes were higher in women than in men (14.11/105 vs. 12.21/105, 12.16/105 vs. 9.71/105; both P<0.05); however, the crude mortality in men increased more rapidly (men: AAPC=4.46%, P<0.05; women: AAPC=1.09%, P>0.05). The YLL, YLD and DALY of diabetes were 155.42, 1 246.73 and 1 402.15 thousand person-years, and the rates of YLL, YLD and DALY were 2.36, 18.90 and 21.25 person-years per thousand, respectively. The rates of YLL, YLD and DALY appeared a tendency towards a rise (AAPC=1.57%, 6.03% and 7.11%, all P<0.05). Higher rates of DALY and more remarkable increase were seen in men than in women (P<0.05; AAPC=8.37%, 5.54%, both P<0.05). Conclusions The mortality of diabetes in Hangzhou City from 2013 to 2021 is high, and the burden of disease, especially disability, is growing rapidly, with the burden of disease being more serious in men.
|
|
Received: 26 May 2023
Revised: 19 August 2023
Published: 06 September 2023
|
|
|
|
|
|
[1] International Diabetes Federation.IDF Diabetes Atlas:10th edition[R].Brussels:IDF,2021.
[2] GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019BD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222.
[3] 中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国慢性病及其危险因素监测报告2013[R].北京:军事医学科学出版社,2016.
[4] 中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国慢性病及危险因素监测报告2018[R].北京:人民卫生出版社,2021.
[5] GBD 2019 Risk Factors Collaborators.Global burden of 87 risk factors in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019BD 2019 Risk Factors Collaborators.Global burden of 87 risk factors in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1223-1249.
[6] 中华医学会糖尿病学分会.《中国糖尿病防治指南》(试行本)(节选)[J].中国慢性病预防与控制,2004,12(6):3.
[7] 刘敏. 我国糖尿病地区分布及其疾病负担研究[D].北京:中国疾病预防控制中心,2019.
[8] 袁晓霞,钟艾霖,周尚成.2017—2019年广州市糖尿病早死概率及疾病负担分析[J].现代预防医学,2021,48(5):784-788.
[9] ZHOU M G,WANG H D,ZENG X Y,et al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2019,394(10204):1145-1158.
[10] 李莹,汪荃,范周全,等.江苏省糖尿病疾病负担及被动吸烟归因疾病负担研究[J].现代预防医学,2019,46(3):394-397,422.
[11] 陈亦晨,孙良红,李小攀,等.1995—2018年上海市浦东新区居民糖尿病死亡特征及减寿率分析[J].中国慢性病预防与控制,2020,28(2):130-133.
[12] 中华人民共和国国家统计局.人口老龄化及其衡量标准是什么[EB/OL].[2023-08-19].http://www.stats.gov.cn/zs/tjws/tjbz/202301/t20230101_1903949.html.
[13] 高明妃,胡如英,胡崇高.中国糖尿病死亡流行特征研究进展[J].预防医学,2022,34(7):692-695.
[14] 聂东梅,李一鹏,黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学,2023,35(7):602-606.
[15] 汪会琴,胡如英,费方荣,等.浙江省2013年2型糖尿病伤残调整寿命年分析[J].中华流行病学杂志,2016,37(1):98-101.
[16] 李镒冲,刘晓婷,胡楠,等.中国2010年糖尿病疾病负担[J].中华流行病学杂志,2013,34(1):33-36.
[17] 曾新颖,齐金蕾,殷鹏,等.1990—2016年中国及省级行政区疾病负担报告[J].中国循环杂志,2018,33(12):1147-1158.
[18] LOVIC D,PIPERIDOU A,ZOGRAFOU I,et al.The growing epidemic of diabetes mellitus[J].Curr Vasc Pharmacol,2020,18(2):104-109.
[19] LEAN M E,LESLIE W S,BARNES A C,et al.Primary care-led weight management for remission of type 2 diabetes(DiRECT):an open-label,cluster-randomised trial[J].Lancet,2018,391(10120):541-551.
[20] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67. |
|
|
|
